181 related articles for article (PubMed ID: 34315400)
1. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.
Aljumaili ZK; Alsamarai AM; Najem WS
J Infect Public Health; 2014; 7(4):277-88. PubMed ID: 24629348
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
4. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of parvovirus B19 specific antibody in pregnant women with spontaneous abortion.
Rahbar N; Vali Zadeh S; Ghorbani R; Kheradmand P
Acta Med Iran; 2015; 53(3):168-72. PubMed ID: 25796023
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
[TBL] [Abstract][Full Text] [Related]
9. [Observations on human parvovirus B19 infection diagnosed in 2011].
Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
[TBL] [Abstract][Full Text] [Related]
10. [Infection with parvovirus B19 in pregnant women].
Oszukowski P; Małafiej E; Pertyński T; Szaflik K; Nowak M; Pieta A; Wierzbicka E; Malinowski A
Ginekol Pol; 1996 Mar; 67(3):114-6. PubMed ID: 8647502
[TBL] [Abstract][Full Text] [Related]
11. [Concentration of interleukin-6 and interleukin-12 in pregnant women infected and noninfected with parvovirus B19].
Friedek D; Romanik M; Rogala-Zawada D; Mercik R; Kłuciński P
Wiad Lek; 2001; 54(9-10):492-7. PubMed ID: 11816291
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-parvovirus B19 IgG and IgM and parvovirus B19 viremia in pregnant women in an urban area of Northern Italy.
De Paschale M; Pavia C; Cerulli T; Cagnin D; Manco MT; Belvisi L; Paganini A; Pogliani L; Ceriani E; Porta A; Parola L; Mirri P; Osnaghi B; Vismara L; Clerici P
J Med Virol; 2022 Nov; 94(11):5409-5414. PubMed ID: 35764590
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.
Searle K; Guilliard C; Enders G
Infection; 1997; 25(1):32-4. PubMed ID: 9039535
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and geographical distribution of parvovirus B19 antibodies in pregnant women: A-meta analysis.
Moosazadeh M; Alimohammadi M; Mousavi T
J Immunoassay Immunochem; 2023 Mar; 44(2):103-116. PubMed ID: 36661768
[TBL] [Abstract][Full Text] [Related]
15. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 in Croatia: A Large-Scale Seroprevalence Study.
Vilibic-Cavlek T; Tabain I; Kolaric B; Mihulja K; Blazevic L; Bogdanic M; Navolan D; Beader N; Mrzljak A
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833497
[No Abstract] [Full Text] [Related]
17. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Zaongo D; Diombo K; Priuli G; Viganò P; Finazzi S; Clerici P
Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
[TBL] [Abstract][Full Text] [Related]
18. The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.
Adam O; Makkawi T; Reber U; Kirberg H; Eis-Hübinger AM
Epidemiol Infect; 2015 Jan; 143(2):242-8. PubMed ID: 24650427
[TBL] [Abstract][Full Text] [Related]
19. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
20. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors.
Jensen IP; Thorsen P; Jeune B; Møller BR; Vestergaard BF
BJOG; 2000 May; 107(5):637-43. PubMed ID: 10826579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
